filmov
tv
Dr. Kopetz on the Importance of Molecular Testing in CRC
Показать описание
OncLive
cancer
oncology
Рекомендации по теме
0:01:14
Dr. Kopetz on the Importance of Molecular Testing in CRC
0:01:39
Dr. Kopetz on the Significance of Tumor Sidedness in CRC
0:01:34
Dr. Kopetz on the Biology of Right- Versus Left-Sided CRC
0:01:38
Dr. Kopetz on the Correlation Between Tumor Sidedness and Biomarkers in CRC
0:01:11
Dr. Kopetz on the Rationale for the BEACON CRC Study in BRAF V600E-Mutant mCRC
0:01:44
Dr. Kopetz Discusses the Treatment of BRAF-Mutant CRC
0:59:06
In this #DocTalk, Dr Scott Kopetz from MD Anderson discusses Minimal Residual Disease in CRC
0:01:00
Dr. Kopetz Discusses Triplet Therapy for BRAF-Mutant CRC
0:02:21
Meet gastrointestinal medical oncologist Scott Kopetz, M.D., Ph.D.
0:01:09
Dr. Kopetz on Updated Data From BEACON CRC Study in BRAF V600E–Mutant CRC
0:00:54
Dr. Kopetz on Safety Data From BEACON CRC Trial in BRAF V600E-Mutant mCRC
0:32:43
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz
0:36:11
Dr. Scott Kopetz from MD Anderson Cancer Center discusses the BREAKWATER trial with Dr. Manju George
0:00:30
Scott Kopetz, MD, PhD, FACP, explains how nivolumab is being incorporated into mCRC treatment
0:02:57
Fight CRC Kopetz Video
0:01:01
Scott Kopetz, MD, PhD, FACP, regarding molecular profile matching in trials with mCRC patients
0:00:58
Scott Kopetz, MD, PhD, FACP, tells us about the outcomes of Checkmate 142 in mCRC patients
0:01:09
The Importance of Molecular Testing in CRC
0:02:49
Moving the Needle 2023 - Panel Three - CA CURE MD Anderson Cancer Center
0:01:06
Scott Kopetz, MD, explains how BRAF mutations figure into treatment algorithms for CRC
0:59:38
Dr Scott Kopetz Deputy Chair, GI Med Oncology MD Anderson discusses KRAS-directed therapies for CRC
0:22:10
Novel Agents and Targets in Colorectal Cancer
0:00:38
Scott Kopetz, MD, PhD, FACP, discusses the incidence of BRAF mutation in CRC patients
0:01:46
Bringing CTCs to the forefront of therapeutics